Programme

  • 08:15

    Registration and refreshments

  • 08:50

    Welcome address

  • 09:00

    Unsure trade war

    Sean King, Senior Vice President, PARK STRATEGIES

  • 09:30

    China M&A: A shifting landscape

    China M&A has rebounded since 2017, with US$422.8bn worth of deals in the first three quarters in 2018 – recorded a 17% increase compared with the same period of 2017. Domestic M&A forges ahead, fuelled by corporate restructuring and divestments. Outbound M&A came to $103.8 billion, following a noticeable slowdown in the second half of the year amidst a climate of protectionism, tighter foreign regulatory oversight, and Sino-US trade tensions. Our panel of senior dealmakers examine the current China M&A landscape and prospects.

    • How are macroeconomic and political developments impacting M&A worldwide and in China?
    • How are the Chinese government’s strategic priorities affecting deal flows?
    • Are PRC regulatory changes enabling M&A? What regulatory challenges do PRC acquirers face overseas?  
    • What are the key lessons from this year’s China M&A wins and misfires?
    • What is the outlook for the next 12 months?

    Moderated by: Yiqing Wang, China Editor, Mergermarket, ACURIS
    Panelists:
    Bagrin Angelov, Head of China Cross-border M&A, Executive Director, CHINA INTERNATIONAL CAPITAL CORPORATION
    Frank Jin, Executive Director, Asia-Pacific Mergers & Acquisitions, MORGAN STANLEY
    Samson Lo, Managing Director, Head of Mergers & Acquisitions, Asia, UBS
    Raghu Narain, Head of Investment Banking, NATIXIS APAC

  • 10:30

    Networking coffee break

  • 11:00

    Chinese outbound: Venturing into new markets

    Chinese companies have responded to government prompting by seeking deals that support the One Belt One Road initiative (OBOR) and local economic growth. Outside developed regions, they have ventured into emerging economies along the Belt and Road, as well as Latin America, where they see potential synergies. However, compelling the thesis, execution is often fraught with difficulty, from deal sourcing and managing risks, to realizing synergies. Our panel of M&A practitioners discuss:

    • Where are the most interesting opportunities and how are they sourced?
    • Which sectors align best with OBOR?
    • Who is participating in these deals?
    • How can private equity play a role?
    • What are the key challenges when entering emerging markets?

    Moderated by: Li Chen, Partner, Mergers & Acquisitions, SHEARMAN & STERLING LLP
    Panelists:
    Yi Bao, Founder & Chairman, CEDERLAKE CAPITAL
    Shengyan Fan, Managing Director, M&A Department, CHINA EVERBRIGHT LIMITED
    Jingkai Huang, Vice Chairman, TEMPUS HOLDINGS LIMITED
    Sen Zhang, Director, Global Fund Management , Chief Executive Officer, JD CAPITAL

  • 11:45

    The rise of control deals in China – where are the real opportunities?

    Driven by founders’ receptiveness to private equity, generational succession issues and SOE carve-outs, investors are attracted by the buoyant opportunities for control deals in China. However, success in this space is contingent on being able to identify the right companies and then forge strong partnerships with them. Our panel of professionals discuss how they are navigating these opportunities.

    • What have been the underlying drivers for more control deals in China?
    • How competitive is deal-sourcing and where are the best prospects?
    • What factors are bringing GPs and strategic investors together? What aligns and what divides them?
    • What are the challenges with founders and management teams, and how can these be overcome?

    Moderated by: Zoe Shi, Partner, Deal Advisory, KPMG ADVISORY (CHINA) LIMITED
    Panelists:
    Brian Chi, Managing Director, THE BLACKSTONE GROUP
    Stephen Dai, Director, Innovative Consumption & Services Investment Dept., LEGEND HOLDINGS
    Gordon Shaw, Managing Director, BARING PRIVATE EQUITY ASIA
    Jim Tsao, Chairman and Head of China, PERMIRA ADVISERS CHINA LIMITED
    Mark Webster, Partner and Managing Director, BDA PARTNERS

  • 12:30

    Networking lunch

  • 13:30

    Fireside Chat: Opportunities for Chinese companies in Southeast Asia

    • What are the dynamics of the consumer markets between China and Southeast Asia, and what is driving cross-border strategic collaborations
    • What business models are best suited for expansion? 
    • How difficult it is to find good local partners? 
    • When does JV/Partnership trump over M&A?

    Moderated by: Patricia Heiberger, Asia Pacific Managing Editor, Mergermarket and Dealreporter, ACURIS
    Panelists:
    Alex Lin, Strategy VP, PING AN GOOD DOCTOR
    Yan Zhang, Director, Corporate Finance, GRAB

  • 14:00

    China and Europe cross-border M&A: Realising the potential

    From critical infrastructure investments in CEE to high-tech companies further west, Europe plays well with China’s development plans. For many European companies, China is also their key market for expansion. Synergies abound, yet to realize these, dealmakers must clear regulatory hurdles, identify targets, and find good partners. Our panel discuss:

    • How have geopolitical factors affected China-Europe cross-border M&A in the past 12 months? How is large and mid-cap deal flow?
    • How will the foreign investment screening proposed by the European Union be developed?
    • What are the most promising sectors for China and Europe cross-border M&A?
    • Which are the opportunities for investing in distressed European assets? What are the potential benefits and pitfalls of distressed M&A transactions for Chinese investors?
    • What values can European private equity firms bring to the Chinese companies when they invest in Europe?

      Moderated by: Eddie Chen, Managing Director and Head of China & Asia, EURAZEO S.E.
      Panelists:
      Tanguy Lesselin, CEO, FINQUEST
      David Russell, Managing Director, VERMILION PARTNERS
      Matthias Weissinger, Partner, Finance, SHEARMAN & STERLING LLP
  • 14:45

    Supercharge your M&A strategies

    Successful M&A deals are few and far between. Those that work require a carefully considered strategy, sophisticated due diligence, experience and skills, as well as the right partners. Our experts examine each key milestone in the deal-making process, as well as the best practices and techniques for a successful closing.

    • How do you identify and woo the right target?
    • What are the critical due diligence activities for acquirers?
    • Are you buying at the right price? How best to evaluate a target’s valuation?
    • How to develop effective communication strategies to increase the likelihood of successful deal completion?
    • What are the proven best practices for post-merger integration?

    Moderated by: Hao Zhou, Partner, BAIN & COMPANY
    Panelists:
    John Gray, Partner, FINSBURY
    Simon Tsang, Managing Director, DUFF & PHELPS
    Jay Weng, Executive Vice President, Managing Director, CHINA FINANCIAL INTERNATIONAL INVESTMENTS LTD
    Jason Zhao, Senior Advisor and Head of Private Equity Investment, CHINA POST LIFE INSURANCE

  • 15:30

    Networking coffee break

  • 16:00

    Hot sector focus: Healthcare

    Chinese companies are becoming more prominent players in global healthcare M&A, fuelled by sector reform, huge demand for quality healthcare, lagging infrastructure and expertise, and global brand-building ambitions. Yet barriers to entry are high, as global strategic and private equity investors snatch the best prospects, and reputational challenges remain. Our sector specialists discuss:

    • What is the reality of healthcare reform in China?
    • Where are the most attractive targets in hospitals, pharma, biotech, and medical devices?
    • What are the success factors and challenges in deal sourcing?
    • What can strategic acquirers learn from private equity due diligence?
    • How can you resolve integration issues and bring in sophisticated technology or unique products for China?

    Moderated by: David Wang, Managing Partner, ADVAN PARTNERS
    Panelists:
    Michael Hua, Director, New Business Development, JOHNSON & JOHNSON MEDICAL ASIA PACIFIC
    Jeff Staples, Chief Operating Officer, UNITED FAMILY HEALTHCARE
    Jonathan Wang, Senior Managing Director, Founding Partner, ORBIMED ASIA
    Steven Wang, Managing and Founding Partner, HIGHLIGHT CAPITAL

  • 16:45

    Hot sector focus: Technology

    Technology shifts are redefining industry boundaries and business models. They are also transforming the tech M&A landscape with a proliferation of players – from companies in traditional industries and unicorns, to private equity and venture players. The acquisition spree has just begun and is expected to continue, with strong Chinese government backing. Our panel of industry practitioners discuss investment strategies amid consolidation and highlight opportunities and challenges.

    • What new areas are strategic and financial investors looking at? What are the hot targets?
    • As technology acquisitions become more sensitive, what should buyers do to maximize their chances for regulatory approval?
    • How effectively have traditional firms utilised and acquired technology to add business value?
    • What are the risks and costs involved in IP and cyber-security related issues?
    • Are we expecting more consolidations of Chinese unicorns and how will this re-shape the landscape over the next five years?

    Moderated by: Tim Burroughs, Managing Editor, ASIAN VENTURE CAPITAL JOURNAL
    Panelists:
    Bennett Cohen, Investment Manager, SHELL VENTURES
    Ashley He, Senior Investment Director, CTRIP.COM INTERNATIONAL, LTD
    Amy Gu, Managing Partner, HEMI VENTURES
    Christian Noske, Managing Director, ALLIANCE VENTURES

  • 17:30

    Closing remarks and end of conference

  • 17:35

    Networking cocktails